Rohto Pharmaceutical

hideThis article has multiple issues. Please help or discuss these issues on the talk page. (Learn how and when to remove these template messages) A major contributor to this article appears to have a close connection with its subject. It may require cleanup to comply with Wikipedia's content policies, particularly neutral point of view. Please discuss further on the talk page. (June 2014) (Learn how and when to remove this template message) This article contains content that is written like an advertisement. Please help by removing promotional content and inappropriate external links, and by adding encyclopedic content written from a neutral point of view. (June 2014) (Learn how and when to remove this template message) (Learn how and when to remove this template message)

Rohto Pharmaceutical Co., Ltd.

Native name	ロート製薬株式会社
Romanized name	Rōto Seiyaku kabushiki gaisha
Type	Public KK
Traded as	TYO: 4527
Industry	FMCG Pharmaceuticals
Founded	Higashinari-ku, Osaka, Japan (September 15, 1949 (1949-09-15), to reorganize "Shintendo, Yasutami Yamada pharmaceutical Company")
Founder	Yasutami Yamada
Headquarters	Ikuno-ku, Osaka, Japan
Key people	Kunio Yamada (chair and CEO, great-grandson of the founder) Toshiaki Yoshino (president and COO)
Revenue	¥120,292 million (FY 2011)[* 1] ¥115,472 million (FY 2010)
Operating income	¥13,624 million (FY 2011)[* 1] ¥13,105 million (FY 2010)
Net income	¥8,184 million (FY 2011)[* 1] ¥7,966 million (FY 2010)
Total assets	¥136,008 million (FY 2011)[* 1] ¥126,472 million (FY 2010)
Total equity	¥83,627 million (FY 2011)[* 1] ¥77,911 million (FY 2010)
Number of employees	5,518 (March 31, 2013)
Subsidiaries	Mentholatum
Website	www.rohto.co.jp/global/
Footnotes / references ^ Jump up to: a b c d e "Financial Results for the Fiscal Year Ended March 31, 2012" (PDF). Rohto Pharmaceutical Co., Ltd. May 11, 2012. Retrieved November 12, 2012.

Rohto Pharmaceutical Co., Ltd. (ロート製薬株式会社, Rōto Seiyaku Kabushiki-gaisha) is a multinational fast-moving consumer goods and pharmaceutical corporation headquartered in Ikuno-ku, Osaka, Japan, with a presence in North America, Europe and Asia. The company is listed on the stock exchange having posted steady increases in revenues from ¥95,619 million in 2006 to ¥120,292 million in 2011. Skin Care contributes to 61.3% of the revenues while Eye Care contributes to 21% of their sales.

Market Segments[]

Rohto is active in the three consumer segments of:

• Beauty (through cosmetics)
• Health (through food supplements)
• Healing (through over-the-counter drugs)

International presence[]

In 1974, Rohto set its eyes on The Mentholatum Company. In August 1975, it acquired the trademark rights to Mentholatum and began to sell the Mentholatum Ointment and Mentholatum Medicated Lip Stick, which proved to be a financial success as the company's revenue skyrocketed to ¥2.64 billion by April 1981. Rohto Pharmaceutical Co. continued to acquire the management rights to The Mentholatum Company Inc in June 1988, thus completing the merge.

Rohto group has established operations in 15 major markets, with marketing/distribution agreements in more than 150 countries globally. They have two production plants in Japan and 6 production plants across US, UK, China, Vietnam, Hong Kong and Indonesia.

Rohto entered the Vietnam market in 1997 and set up their manufacturing base to cater to the Asia Pacific market. In mid-2010, Rohto entered the India market and started operations in the lipcare and skin care segment, with their internationally popular brands, Lipice and Oxy. Simultaneously they also entered the Bangladesh market.

With a strong presence across international markets, the company has a manpower strength of close to 5000 employees.

Yasutami Yamada (山田 安民, Yamada Yasutami) founded "Shintendo, Yasutami Yamada Pharmaceutical Company (信天堂山田安民薬房)", the predecessor of Rohto, in Shimizucho, Higashi-ku (present: Shinsaibashi, Chuo-ku), Osaka on February 22, 1899. Yamada sold "Rohto Eyedrops" in 1909. "Rohto" was named after August von Rothmund,^{[note 1]} a German ophthalmologist who was a professor for Toyotaro Inoue (井上 豊太郎, Inoue Toyotarō), a Japanese ophthalmologist.

Brands[]

• Lipice: The best selling Lip Care line in Japan, China, HK, Taiwan, Vietnam, Malaysia, Singapore, Thailand & Indonesia.
• Oxy B: Anti-acne products(acquired the OXY Skin Care branding from GlaxoSmithKline in December 2005)
• Rohto Eyedrops: including the highly acclaimed Rohto Zi (Awarded "Best New Eyecare Product" in the 1999 Superdrug Health & Beauty Awards)
• Sunplay: Full range of sunscreen daily sun care and after sun products providing best UV protection for different outdoor occasions
• BodyIce: Deodorant roll-on and mists
• Mentholatum: Full range of Men's skin care for face and body
• Selsun: Anti-dandruff shampoo
• Acnelogy: pimples treatment (Acne + Dermatology.It includes 3 skincare steps (Conditioning Foam, Acne Care Lotion, Concentrate Essence)

Head Office and Subsidiaries[]

• Rohto Pharmaceutical Co., Ltd. (Japan - Parent Company)
• Mentholatum Australasia Pty. Ltd.(Australia)
• The Mentholatum Company Ltd. (UK)
• The Mentholatum Company of (Canada), Limited
• The Mentholatum (China) Pharmaceuticals Co., Ltd.
• Mentholatum Asia Pacific Ltd. (Hong Kong)
• Rohto Pharma (India) Private Limited
• Mentholatum de (Mexico), S.A. de C.V.
• Mentholatum (South Africa) Pty. Ltd.
• Mentholatum Taiwan Ltd. (Taiwan)
• PT Rohto Laboratories (Indonesia)
• Rohto-Mentholatum (Vietnam) Co., Ltd.
• Rohto-Mentholatum (Malaysia) SDN BHD.
• Rohto-Mentholatum (Thailand) Ltd.
• Rohto-Mentholatum (Bangladesh) Limited
• Dax Cosmetics Sp. z o.o. (Poland) Limited

Notes[]

External links[]

• Rohto global website(in English)
• Rohto Products Information/樂敦產品中文介紹(in Chinese)
• Rohto eyedrops website